The State-of-the-Art in Interstitial Lung Disease (ILD)

A special issue of Journal of Respiration (ISSN 2673-527X).

Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 650

Special Issue Editor


E-Mail Website
Guest Editor
Department of Clinical Pathology and Cytology, Karolinska University Hospital, Karolinska Institute, SE-17176 Stockholm, Sweden
Interests: cancer biology; cancer biomarkers; pathology; cancer research
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Interstitial lung diseases (ILDs) are a group of respiratory diseases, often idiopathic, that frequently affect older people in the general population. Altogether, ILD patients represent about 15% of all patients referred to respiratory medicine. The diagnosis still remains a challenge, and a multidisciplinary team is mandatory for an optimal therapy. This Special Issue of Journal of Respiration invites contributions that summarize the state-of-the-art of current research, new entities, and multidisciplinary approaches to studying and treating ILDs. We invite contributions on well-established topics in the radiological and pathological diagnosis of ILDs, such as IPF, environment-related diseases, autoimmune diseases, and lung transplantation, but also in new emerging topics, such as the role of the potential of AI in ILD diagnosis or post-COVID-19 manifestations in the family of ILDs.

Dr. Cristian Ortiz Villalon
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Respiration is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • interstitial lung diseases
  • ILD
  • IPF
  • lung transplantation
  • ILD diagnosis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop